Tennessee Oncology is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.
Tennessee Oncology has participated in 275 clinical trials with 93 currently active.
Therapeutic areas: Breast Cancer, Renal Cell Carcinoma, Multiple Myeloma.
Sponsors: Infinity Pharmaceuticals, Inc., K36 Therapeutics, Inc., SCRI Development Innovations, LLC.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Tennessee Oncology has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Tennessee Oncology has 275 clinical trials on record, with 93 currently active. Their work covers Breast Cancer, Renal Cell Carcinoma, Multiple Myeloma.
Tennessee Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.